American College

Curio Digital Therapeutics Inc. Announces the U.S. Food and Drug Administration (FDA) Clearance of MamaLift Plus™, the First Prescription Digital Therapeutic Authorized for the Treatment of Postpartum Depression (PPD)

Retrieved on: 
Tuesday, April 23, 2024
Mental Health, Women, FDA, Baby, Maternity, Clinical Trials, Biotechnology, Health, Consumer, Pharmaceutical, American College, Regulation, PPD, Woman, Behavioral activation, Food, Cognitive behavioral therapy, BAT, Depression, DBT, Smartphone, Summer, ACOG, Therapy, Edinburgh Postnatal Depression Scale, Patient, MPH, Postpartum depression, Face, ITT, IPT, RCT, Dialectical behavior therapy, CBT, EPDS

Curio Digital Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance to MamaLift PlusTM.

Key Points: 
  • Curio Digital Therapeutics Inc. announced that the U.S. Food and Drug Administration (FDA) has granted clearance to MamaLift PlusTM.
  • MamaLift Plus treats mild to moderate postpartum depression by improving a patient’s symptoms of depression.
  • MamaLift Plus delivers digital Cognitive Behavioral Therapy (CBT), Behavioral Activation Therapy (BAT), Interpersonal Therapy (IPT), and Dialectical Behavior Therapy (DBT) for postpartum depression.
  • The clearance of MamaLift Plus is based on results from the Supporting Maternal Mental Health and Emotional Regulation (SuMMER).

New Study Reveals 65 and Older Population Lowered Blood Pressure, Cholesterol, and Weight Using Mobile Technology

Retrieved on: 
Tuesday, April 23, 2024
Cardiology, Health, Medical Devices, Health Technology, Wearables, Mobile Technology, Technology, Apps, Applications, Mobile, Wireless, Stroke, American College, SBP, Risk, Blood pressure, CVD, Heart, BMI, Death, Conference, Artificial intelligence, Heart rate, SVP, Patient, Splenic infarction, Cholesterol, Physician, Medicare, LDL, Cardiovascular disease, BP, Ageing

The study observed 8,148 Hello Heart users aged 65 and over who were equipped with the Hello Heart connected monitor and mobile app.

Key Points: 
  • The study observed 8,148 Hello Heart users aged 65 and over who were equipped with the Hello Heart connected monitor and mobile app.
  • Study participants showed a 45% higher engagement rate compared to Hello Heart users younger than 65.
  • “Results from this study challenge the assumption that our aging population struggles to use smartphones or are resistant to using technology to manage their health,” said Edo Paz, MD, SVP, Medical Affairs, Hello Heart.
  • “There’s a significant untapped opportunity to engage this age group with scalable mobile technology to help them better understand their CVD risk and take steps to improve their heart health.”

Houston Will Host 2025 ACHE Congress Bringing More than 5,000 Healthcare Leaders to City

Retrieved on: 
Tuesday, April 23, 2024
Men, General Health, Professional Services, Nursing, Digital Marketing, Consumer, Other Communications, Health, Public Relations, Investor Relations, Other Education, Marketing, Training, Communications, Primary, Secondary, Education, Women, Consulting, Congress, Society, Bangladesh Technical Education Board, Associated, American College, Learning, GRB, Travel, Health care, Physicist, CAE, National Institutes of Health, Microbiology, American Dental Association, Houston First Corporation, Greater Houston Partnership, ACHE, Pharmaceutical industry

Houston will host the American College of Healthcare Executives’ annual Congress on Healthcare Leadership in March 2025.

Key Points: 
  • Houston will host the American College of Healthcare Executives’ annual Congress on Healthcare Leadership in March 2025.
  • The industry group announced next year’s host city at the end of this year’s Congress late last month in Chicago.
  • ACHE Congress will bring more than 5,000 healthcare and industry leaders from around the country to the George R. Brown Convention Center (GRB) March 24 -27, 2025.
  • “We’re honored that ACHE has chosen to hold their 2025 Congress in Houston,” said Michael Heckman, President and CEO of Houston First Corporation, the regional destination marketing organization that booked the conference.

Simpson Interventions Receives FDA Breakthrough Device Designation for Acolyte™ Image Guided Crossing and Re-Entry Catheter System

Retrieved on: 
Thursday, April 11, 2024
Medical Devices, FDA, Health, Health Technology, Radiology, Cardiology, Operational technology, Catheter, American College, Coronary artery disease, Food, MD, Angioplasty, Interventions, OCT, Patient, Diagnosis, Plaque, Journal, Medical imaging

Simpson Interventions, Inc., a pioneering medical technology company specializing in cardiovascular interventional devices, today announced that its groundbreaking Acolyte Image Guided Crossing and Re-Entry Catheter System has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).

Key Points: 
  • Simpson Interventions, Inc., a pioneering medical technology company specializing in cardiovascular interventional devices, today announced that its groundbreaking Acolyte Image Guided Crossing and Re-Entry Catheter System has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA).
  • The Acolyte Image Guided Crossing and Re-Entry Catheter System aims to overcome these challenges by providing clinicians with this breakthrough device that has enhanced visualization and navigation capabilities, ultimately improving CTO crossing, procedural success rates, and patient outcomes.
  • "We are thrilled to receive FDA's Breakthrough Device Designation for our Acolyte Image Guided Crossing and Re-Entry Catheter System," said Dr. John B. Simpson, PhD, MD, Founder and CEO of Simpson Interventions.
  • Simpson Interventions is committed to collaborating closely with the FDA and other stakeholders to advance the development and regulatory review of the Acolyte Image Guided Crossing and Re-Entry Catheter System.

Imperial College London Study Shows Groundbreaking Final Results for SHL Telemedicine’s SmartHeart® in Post-ACS Patient Care

Retrieved on: 
Thursday, April 11, 2024
Technology, Biotechnology, Health, Biometrics, Apps, Applications, Other Health, Telemedicine, Virtual Medicine, Medical Devices, Software, Managed Care, Hospitals, Health Technology, Clinical Trials, Cardiology, American College, Telehealth, ACC, Periodic breathing, Dizziness, ECG, Imperial College London, Patient, Multimedia, Chest pain, SHL, Photograph, ED, Medical imaging

SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, is excited to announce the groundbreaking full results of the Imperial College London TELE-ACS Trial.

Key Points: 
  • SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine solutions, is excited to announce the groundbreaking full results of the Imperial College London TELE-ACS Trial.
  • The TELE-ACS clinical trial, conducted at a large tertiary center in London, UK, from January 2022 to April 2023, involved 337 participants.
  • Moreover, the study was also published in the leading Journal of the American College of Cardiology (JACC).
  • These groundbreaking clinical results are an endorsement that propels us forward in our mission to redefine patient care, demonstrating the tangible benefits and efficiency of our telemedicine solutions on a global scale."

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

Retrieved on: 
Thursday, April 25, 2024
Society, American College, Certification, Medical specialty, Cardiology, Outline, Comment, Patient, ABMS, Physician, American Heart Association, Nursing

WASHINGTON, April 25, 2024 /PRNewswire/ -- Efforts by the American College of Cardiology, the American Heart Association, the Heart Failure Society of America, the Heart Rhythm Society and The Society for Cardiovascular Angiography & Interventions to create a new, independent Board of Cardiovascular Medicine under the American Board of Medical Specialties (ABMS) are closer to becoming a reality with the creation of a formal Board of Directors and the announcement by the ABMS Advisory Board on Specialty Board Development of an open comment period.

Key Points: 
  • Running through July 24, ABMS is seeking to gauge support for the new Board, including feedback on its impact to clinicians and patients.
  • "The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board."
  • As leaders in their respective fields, the Board of Directors will be instrumental in ushering the new Board through the application process and overseeing pre-launch projects in anticipation of Board approval.
  • "An independent Board focused solely on cardiovascular medicine as a distinct medical specialty will ultimately benefit cardiologists and patients alike."

Sage Veterinary Imaging Welcomes New President

Retrieved on: 
Thursday, April 25, 2024
University, CFO, American College, ACVR, Boehringer Ingelheim, Purdue University, SVI, Business school, Business, Patient, Health, Therapy

ROUND ROCK, Texas, April 25, 2024 /PRNewswire/ -- Sage Veterinary Imaging (SVI) has welcomed Peter Selover to its team as president and chief operating officer. Selover had previously served as chief executive officer of Exubrion Therapeutics.

Key Points: 
  • ROUND ROCK, Texas, April 25, 2024 /PRNewswire/ -- Sage Veterinary Imaging (SVI) has welcomed Peter Selover to its team as president and chief operating officer.
  • SVI founder, Dr. Jaime Sage, will maintain her role in providing the highest quality veterinary imaging to referring veterinarians and their clients.
  • In addition to the three Sage Veterinary Imaging centers in Texas and Utah, SVI is one of only 25 residency programs accredited by the American College of Veterinary Radiology (ACVR) as a teaching hospital.
  • "Dr. Sage and her team are meeting the growing need for higher quality veterinary imaging.

Four FBFK Attorneys Named to 2024 D Magazine Best Lawyers in Dallas

Retrieved on: 
Wednesday, April 24, 2024
Lawyer, Law, D Magazine, American College, AV, Bar association, Intellectual property, Cone, Private practice, Partnership, Employment, Dedman School of Law, Patent, Baylor Law School, Methodist University, Tax law, Marketing, Intellectual, Organization, Chambers and Partners

DALLAS, April 24, 2024 /PRNewswire-PRWeb/ -- The FBFK law firm is proud to announce that, once again, intellectual property shareholder Kelly Kubasta and of counsel intellectual property attorney John Cone, tax law shareholder Dan Baucum, and employment law shareholder Todd Shadle have been named among 2024 D Magazine Best Lawyers in Dallas. The annual, peer-nominated list honors "exceptional lawyers offering unparalleled counsel" in 40 categories across Dallas.

Key Points: 
  • DALLAS, April 24, 2024 /PRNewswire-PRWeb/ -- The FBFK law firm is proud to announce that, once again, intellectual property shareholder Kelly Kubasta and of counsel intellectual property attorney John Cone, tax law shareholder Dan Baucum, and employment law shareholder Todd Shadle have been named among 2024 D Magazine Best Lawyers in Dallas.
  • "We're grateful for this honor and thank D Magazine for spotlighting this group of incredibly talented, highly respected FBFK attorneys," said Kyle Ferguson, FBFK CEO and Founding Partner.
  • "We're grateful for this honor and thank D Magazine for spotlighting this group of incredibly talented, highly respected FBFK attorneys," said Kyle Ferguson, FBFK CEO and Founding Partner.
  • He was recently named to the 2024 D CEO Dallas 500, to The Lawdragon 500: Leading Corporate Employment Lawyers Guide for seven consecutive years, is a three-time Texas Super Lawyer, named among the "Best Lawyers in Dallas" by D Magazine, a five-time honoree by the Best Lawyers in America, and is rated AV Preeminent® by Martindale-Hubbell®.

American College of Lifestyle Medicine supports proposed law requiring protections for children from ultra-processed, sugar-sweetened foods and beverages

Retrieved on: 
Tuesday, April 23, 2024
Nutrition, CME, American College, Health, Overweight, ACLM, Collection, Conference, Habit, White House conference, Obesity, Pediatrics, Diet, Physician, Food, Pediatric Obesity, Medicine, Conditional sentence, Harvard Medical School, Eating, Drink, Soft drink

Lifestyle medicine-certified clinicians are trained to apply evidence-based, whole-person, prescriptive lifestyle changes to treat and, when used intensively, often reverse common noncommunicable chronic diseases. Applying the six pillars of lifestyle medicine—a whole-food, plant-predominant eating pattern, physical activity, restorative sleep, stress management, positive social connections and avoidance or minimization of risky substances and behaviors--also provides effective prevention of these conditions.

Key Points: 
  • More than 300 ACLM members are pediatricians, several of whom serve in organization leadership roles.
  • Lifestyle medicine-certified clinicians are trained to apply evidence-based, whole-person, prescriptive lifestyle changes to treat and, when used intensively, often reverse common noncommunicable chronic diseases.
  • "We also know that children and adolescents who experience obesity are five times more likely to experience it as adults.
  • In support of the 2022 White House Conference on Hunger, Health and Nutrition, ACLM is also offering a 5.5-hour complimentary CE/CME introductory course on food as medicine and lifestyle medicine.

2024 Annual Meeting of the American College of Clinical Pharmacology® - The Premier Clinical Pharmacology Educational & Scientific Meeting

Retrieved on: 
Tuesday, April 23, 2024
ACCME, Accreditation Council, American College, CME, Trainee, ACPE, Student, PBPK, Health, Accreditation, Drug development, Continuing medical education, ACCP, Pharmacology, Nursing

ASHBURN, Va. , April 23, 2024 /PRNewswire/ -- The American College of Clinical Pharmacology® (ACCP) is pleased to announce its 2024 ACCP Annual Meeting (#2024ACCP) will be held September 8 – 10, 2024. We encourage you to join us for this transformative educational and scientific event! ACCP provides healthcare professionals and scientists with a forum to exchange knowledge and ideas that promote and expand the value of clinical pharmacology in healthcare and drug development.

Key Points: 
  • ASHBURN, Va. , April 23, 2024 /PRNewswire/ -- The American College of Clinical Pharmacology® (ACCP) is pleased to announce its 2024 ACCP Annual Meeting (#2024ACCP) will be held September 8 – 10, 2024.
  • We encourage you to join us for this transformative educational and scientific event!
  • ACCP provides healthcare professionals and scientists with a forum to exchange knowledge and ideas that promote and expand the value of clinical pharmacology in healthcare and drug development.
  • Green, President, ACCP stated, "I am pleased to formally invite you to the 2024ACCP Annual Meeting in Bethesda, MD!